Hemocoagulase, developed by Swiss Sugo Pharmaceuticals, is a high-purity, single-component hemagglutinin clinical hemostatic drug. Its original drug is called REPTILASE, which is not on the market in China. In 2009, Hemocoagulase was firstly launched in China. Its product, Suling was developed by Beijing Kangchen Pharmaceutical Co., Ltd. Since then, some generic drugs have also been listed in the Chinese market. According to CRI’s market research, there are 4 manufacturers in the Chinese Hemocoagulase market by 2020, among which Beijing Kangchen Pharmaceutical Co., Ltd. accounts for the most market share.
According to CRI’s market research, the sales value of Hemocoagulase in the Chinese market is relatively stable from 2016 to 2019. In 2020, due to the impact of COVID-19 on the overall diagnosis and treatment services of the hospital, the sales value of Hemocoagulase in the Chinese market fell to CNY694 million in 2020, a year-on-year decline of 32%. The CAGR of Hemocoagulase sales value in the Chinese market from 2016 to 2020 is -11.05%.
CRI expects that with the relief of COVID-19, the sales value of Hemocoagulase in the Chinese market will have a restorative growth from 2021 to 2025. In addition, the Hemocoagulase injection is targeted, which cannot cause hypercoagulability in the blood. Based on this advantage, the sales value and sales volume of Hemocoagulase have a certain room for growth. At the same time, in the first half of 2021, China introduced a policy to encourage each couple to have three children. With the help of a new round of “baby boom” that may come, China’s procoagulant hemostatic drugs have a better market prospect, and sales value of Hemocoagulase are expected to be on the rise from 2021 to 2025.
- -The impact of COVID-19 on China’s Hemocoagulase market
- – Sales value of China’s Hemocoagulase 2016-2020
- – Competitive landscape of China’s Hemocoagulase market
- – Prices of Hemocoagulase in China
- – Prices of Hemocoagulase in China by regions and manufacturers
- – Analysis on factors affecting the development of China’s Hemocoagulase market
- – Prospect of China’s Hemocoagulase market from 2021 to 2025